Trial intelligence / Profile preview

Adjuvant radiation versus chemoradiation in intermediate-risk stage I/IIa cervical cancer after radical hysterectomy

KCT0003504Phase 3Recruiting

Sponsor
Asan Medical Center
Start
Sep 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of cisplatin in Cervical Cancer (CC) (2 arms), sponsored by Asan Medical Center. Started Sep 2010; status: recruiting.

02

Drugs

cisplatin
03

Conditions

Cervical Cancer (CC)

Beyond the preview

Go deeper on KCT0003504.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0003504.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call